OrbiMed’s Turnstone Biologics TSBX Stock Holding History

OrbiMed’s Portfolio TSBX Stock Details TSBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,099,265	Closed	-$1.11M	–	121
2025 Q2	$1.11M	Hold	3,099,265	–	–	0.03%	91
2025 Q1	$1.27M	Hold	3,099,265	–	–	0.03%	99
2024 Q4	$1.54M	Hold	3,099,265	–	–	0.03%	106
2024 Q3	$1.73M	Hold	3,099,265	–	–	0.03%	112
2024 Q2	$8.12M	Hold	3,099,265	–	–	0.16%	79
2024 Q1	$8.12M	Hold	3,099,265	–	–	0.15%	88
2023 Q4	$7.89M	Hold	3,099,265	–	–	0.16%	84
2023 Q3	$12.2M	Buy	+3,099,265	New	+$27.6M	0.26%	75

OrbiMed's TSBX Position: Q3 2025 in Review

OrbiMed sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 3,099,265 shares — an estimated $1.11M sold.

OrbiMed first reported a position in TSBX in Q3 2023 and held it in 8 quarters. The position peaked at $12.2M in Q3 2023. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

OrbiMed reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
OrbiMed sold 3,099,265 Turnstone Biologics shares in Q3 2025, an estimated $1.11M.
OrbiMed first reported a position in Turnstone Biologics in Q3 2023 and held it in 8 quarters.
OrbiMed's Turnstone Biologics position peaked at $12.2M in Q3 2023.
1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on OrbiMed's 13F filing for Q3 2025, filed 14 Nov 2025.